On March 26, 2025, Mycobacterium tuberculosis Rifampin and Isoniazid-resistance Mutation Test Kit (LAMP-Melting Curve Analysis)

 from Suzhou GenePark Technology Co., Ltd. was officially obtained the registration certificate of Class III medical devices from the NMPA. 

(The National Medical Device Registration Approval 20253400643)

 

The product is used for in vitro qualitative detection of mutations related to rifampicin resistance and isoniazid resistance

 in solid or liquid isolates of Mycobacterium tuberculosis complex positive sputum samples from tuberculosis patients. 

 

The inspection time can be reduced to less than 2 hours.

Mycobacterium tuberculosis Rifampin and Isoniazid-resistance Mutation Test Kit (LAMP-Melting Curve Analysis)